Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

University of Oxford Medical School continues to outperform the rest of the UK's medical schools.

99% of all University of Oxford Medical School graduates are satisfied with the quality of their course, according to the latest figures from the 2014 National Student Survey.

The Oxford BM BHc (Hons) Medicine course tops the league tables for student satisfaction for the second year running, followed closely by medical schools at Keele (96%), Brighton and Sussex (96%), Exeter (96%) and Queen Mary University of London (95%).

The online National Student Survey is offered to recent graduates from all UK higher education degree courses, covering employment, course and accommodation costs, study information and satisfaction.

Based on the 22 satisfaction-related questions answered one (definitely disagree) to five (definitely agree) by respondents, The University of Oxford’s mean satisfaction score in 2014 for medicine is 4.66, with 86% of students answering ‘definitely agree’ to the question ‘overall, I am satisfied with the quality of the course’. This was significantly higher than other UK medical schools included in the survey.

Dr Tim Lancaster, Director of Clinical Studies, Oxford Medical School, said: ‘I am delighted that once again Oxford has achieved the highest student satisfaction ratings of all UK medical schools, and am deeply grateful to the teachers who have contributed to this result. The GMC’s National Training Survey shows that Oxford graduates also report above average levels of preparedness for undertaking Foundation posts, and recent data from Membership examinations of the Royal College of Physicians and the Royal College of Practitioners show that Oxford graduates as a whole reach high levels of achievement  in both written and clinical examinations. Delivering graduates who can provide service of the highest quality to the NHS is a key goal of undergraduate medical education, and all these indicators suggest that Oxford is meeting that goal ‘

See more results for Oxford in the National Student Survey. 

-----------------------------------------------------------------------------------------------------------------------------------------------

Text compiled by Dan Richards-Doran. See related item on Nuffield Department of Primary Health Care website.

Similar stories

Latest data on immune response to COVID-19 reinforces need for vaccination, says Oxford-led study

A new study led by the University of Oxford has found that previous infection, whether symptomatic or asymptomatic, does not necessarily protect you long-term from COVID-19, particularly against new Variants of Concern.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.